Company news
Odyssey Health Inc. (OTC:ODYY) news
Odyssey Health Inc. news releases on 6ix. Latest, Apr 22, 2026: Odyssey Health, Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive…
Press releases & updates
Odyssey Health, Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive Recurring Revenue Growth
April 22, 2026
Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million
November 19, 2025
Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace
October 16, 2025
Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device
August 26, 2025
Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity
March 26, 2024
Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc.
January 1, 2024
Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc.
December 11, 2023
Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion
November 15, 2023
Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders
November 14, 2023
Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc.
October 17, 2023
OTC Markets Group Welcomes New OTCQB Companies – October 9
October 9, 2023
Brett Favre Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
July 13, 2022
Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device
October 19, 2021
Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion
September 22, 2021
Odyssey Group International to Present at the HC Wainwright 23rd Annual Global Investment Conference
September 9, 2021
Odyssey Group International Approved to Start Human Trial to Treat Concussion
September 1, 2021
Odyssey Group International Completes Final Drug-Device Combination Product in Preparation for Clinical Trial Launch
August 30, 2021
Odyssey Group International and Super Bowl MVPs Featured on “Banfield” Discussed Novel Concussion Treatment
August 6, 2021
Odyssey Group International Completes IND-enabling Studies, Submits Investigator’s Brochure for Phase 1 Clinical Trial
August 4, 2021
The Odyssey Group International Sports Advisory Board Including Three Super Bowl MVPs will Appear on “Banfield” to Discuss Concussion Treatments
July 27, 2021
Odyssey Group International, Inc. Provides Notice of Annual Meeting of Stockholders
July 26, 2021
Odyssey Group International Reports Achieving Drug Safety Standards for Clinical Trials of its Drug for Treating Concussion
June 29, 2021
Odyssey Group International to Present at LD Micro Virtual Investor Conference
June 8, 2021
Odyssey Group International Announces Successful Completion of Their Novel Nano-Particle Drug Formulation for Treating Concussion
June 2, 2021
Odyssey Group International Announces Successful Toxicology Studies for its Concussion Drug
May 26, 2021
Odyssey Group International, Inc. Schedules Annual Meeting of Stockholders
May 24, 2021
Odyssey Group International Announces Completion of Novel Device for Nasal Delivery of Concussion Drug Candidate
May 19, 2021
Odyssey Group International Welcomes Global Operations and Quality Leader Ricky Richardson to Board of Directors
May 13, 2021
Odyssey Group International Welcomes Dr Bob Arnot to Scientific Advisory Board
May 11, 2021
Odyssey Group International Announces Formation of Scientific Advisory Board
April 14, 2021
Odyssey Group International Welcomes World Cup Winner Abby Wambach to Sports Advisory Board
March 30, 2021
Odyssey Group International to Present at Virtual Investor Summit on March 24, 2021 at 2:30 PM ET
March 21, 2021
Odyssey Group International Announces Formation of Sports Advisory Board to Enhance Awareness of Traumatic Brain Injuries and Concussions
March 17, 2021
Odyssey Group International Announces Upcoming Television Appearance by Brett Favre and Dr. Jake VanLandingham on NewsNation Now’s “The Donlon Report”
March 9, 2021
Odyssey Group International, Inc. Closes Acquisition of Novel Concussion Drug
March 1, 2021
Odyssey Group International Completes Design Phase and Moves Into Prototype Phase for Its Save A Life Choking Rescue Device
February 23, 2021
Odyssey Group International/Prevacus, Inc. Reports Brain Bio-Distribution Findings of PRV-002
February 16, 2021
Odyssey Group International Announces Recent Television Segments on Fox Business, CheddarTV and Newsmax
February 8, 2021
Odyssey Group International's Planned Acquisition of Concussion Drug from Prevacus, Inc. Enhances Delivery Capabilities with Nasal Therapeutic
January 25, 2021
Odyssey Group International's Planned Acquisition of Concussion Drug from Prevacus, Inc. Provides Positive Data from Ongoing Stability Studies
January 19, 2021
Odyssey Group International to Acquire Concussion Drug Asset from Prevacus, Inc.
January 10, 2021
Odyssey Group International Advances Development of its Save A Life Choking Rescue Device
December 15, 2020
Odyssey Group International Provides Fiscal Year End July 31, 2020 Update
December 6, 2020
Odyssey Group International Announces $10,250,000 Common Stock Purchase Agreement with Lincoln Park Capital Fund to Support its Long-Term Growth
August 19, 2020
Odyssey Group International Issues Statement Regarding Unauthorized Promotional Activity Involving its Common Stock
June 10, 2020
Odyssey Group International Strengthens Balance Sheet
June 8, 2020
Odyssey Group International Provides Update on the Development of its Save a Life Choking Rescue Device
May 13, 2020
Odyssey Group International Provides Progress Update on its Life-Saving Medical Products
March 30, 2020
Odyssey Group International Signs Agreement with Majic LLC
March 1, 2020
Odyssey Group International Appoints Mike Contarino to Lead Product Development Programs
February 9, 2020